Accuracy of Dose Calibrators for ⁶⁸Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment

Abstract

We report the discovery of a systematic miscalibration during the work-up process for site validation of a multicenter clinical PET imaging trial using Ga, which manifested as a consistent and reproducible underestimation in the quantitative accuracy (assessed by SUV) of a range of PET systems from different manufacturers at several different facilities around Australia. Sites were asked to follow a strict preparation protocol to create a radioactive phantom with Ga to be imaged using a standard clinical protocol before commencing imaging in the trial. All sites had routinely usedGa for clinical PET imaging for many years. The reconstructed image data were transferred to an imaging core laboratory for analysis, along with information about ancillary equipment such as the radionuclide dose calibrator. Fourteen PET systems were assessed from 10 nuclear medicine facilities in Australia, with the aim for each PET system being to produce images within 5% of the true SUV. At initial testing, 10 of the 14 PET systems underestimated the SUV by 15% on average (range, 13%-23%). Multiple PET systems at one site, from two different manufacturers, were all similarly affected, suggesting a common cause. We eventually identified an incorrect factory-shipped dose calibrator setting from a single manufacturer as being the cause. The calibrator setting forGa was subsequently adjusted by the users so that the reconstructed images produced accurate values. PET imaging involves a chain of measurements and calibrations to produce accurate quantitative performance. Testing of the entire chain is simple, however, and should form part of any quality assurance program or prequalifying site assessment before commencing a quantitative imaging trial or clinical imaging.

TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

“…This will include certification of 68 Ga‐PSMA‐11 and 177 Lu‐PSMA‐617 production and 68 Ga PET/CT camera validation. The 68 Ga‐PSMA‐11 quality control parameters have been replicated from the Movember/PCFA ProPSMA study . 68 Ga‐PSMA‐11 administration and PET/CT acquisition are standardized across sites according to the study nuclear medicine manual.…”

A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga, 44Sc, 177Lu and 161Tb

“…In a recent study, accuracy of four different types of radionuclide calibrators was investigated for 68 Ga by using well-calibrated gamma spectrometry. The results were surprising in that all the radionuclide calibrator systems showed a systematic error in the range of 10-25% [76,146]. It was reported that the deviations were mainly due to the incorrect factory-shipped dose calibrator setting.…”

An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theranostics

“…Recent studies [9][10][11] demonstrated large measurement deviations ( > ± 10%) for several individual diagnostic radionuclides commonly used (particularly for 111 In and 68 Ga). However, no large multi-center studies have reported on the impact of radionuclide calibrator accuracy on activity measurements in the increasing application of personalized molecular radiotherapy based on a theranostic approach.…”